Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery
…, R Zangerle, O Katsarou, F Dabis… - Clinical infectious …, 2014 - academic.oup.com
Background. Some human immunodeficiency virus (HIV)–infected individuals initiating
combination antiretroviral therapy (cART) with low CD4 counts achieve viral suppression but not …
combination antiretroviral therapy (cART) with low CD4 counts achieve viral suppression but not …
[PDF][PDF] Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries
MWG Brinkhof, F Dabis, L Myer… - Bulletin of the World …, 2008 - SciELO Public Health
OBJECTIVE: To analyse the early loss of patients to antiretroviral therapy (ART) programmes
in resource-limited settings. METHODS: Using data on 5491 adult patients starting ART (…
in resource-limited settings. METHODS: Using data on 5491 adult patients starting ART (…
[HTML][HTML] Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission
F Dabis, L Bequet, DK Ekouevi, I Viho… - AIDS (London …, 2005 - ncbi.nlm.nih.gov
… François DABIS was the director and co-primary investigator of the entire project, supervised
the epidemiological aspects of the study, wrote the manuscript. Laurence BEQUET was the …
the epidemiological aspects of the study, wrote the manuscript. Laurence BEQUET was the …
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
…, M May, G Chêne, AN Phillips, B Ledergerber, F Dabis… - The Lancet, 2002 - thelancet.com
Background Insufficient data are available from single cohort studies to allow estimation of
the prognosis of HIV-1 infected, treatment-naive patients who start highly active antiretroviral …
the prognosis of HIV-1 infected, treatment-naive patients who start highly active antiretroviral …
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D: A: D) …
…, C Smith, R Weber, P Reiss, F Dabis… - European journal of …, 2016 - journals.sagepub.com
Background With the aging of the population living with HIV, the absolute risk of cardiovascular
disease (CVD) is increasing. There is a need to further facilitate the identification of …
disease (CVD) is increasing. There is a need to further facilitate the identification of …
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial
Background Universal antiretroviral therapy (ART), as per the 2015 WHO recommendations,
might reduce population HIV incidence. We investigated the effect of universal test and treat …
might reduce population HIV incidence. We investigated the effect of universal test and treat …
Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa
…, S Wiktor, R Nduati, P Msellati, F Dabis… - International journal …, 2011 - academic.oup.com
Background Previously, HIV epidemic models have used a double Weibull curve to represent
high initial and late mortality of HIV-infected children, without distinguishing timing of …
high initial and late mortality of HIV-infected children, without distinguishing timing of …
Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis
…, M Cortina-Borja, N Rollins, P Gaillard, F Dabis - The Lancet, 2004 - thelancet.com
Background HIV contributes substantially to child mortality, but factors underlying these
deaths are inadequately described. With individual data from seven randomised mother-to-child …
deaths are inadequately described. With individual data from seven randomised mother-to-child …
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.
P Braitstein, MW Brinkhof, F Dabis… - Lancet (London …, 2006 - europepmc.org
Background Highly active antiretroviral therapy (HAART) is being scaled up in developing
countries. We compared baseline characteristics and outcomes during the first year of HAART …
countries. We compared baseline characteristics and outcomes during the first year of HAART …
6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and …
F Dabis, P Msellati, N Meda, C Welffens-Ekra, B You… - The Lancet, 1999 - thelancet.com
Background Zidovudine reduces the rate of vertical transmission of HIV in non-breastfed
populations. We assessed the acceptability, tolerance, and 6-month efficacy of a short regimen …
populations. We assessed the acceptability, tolerance, and 6-month efficacy of a short regimen …
